RecruitingACTRN12625000040460

Preoperative Laser Depilation of Donor Site in Head and Neck Cancer Free Flap Reconstruction [LaDDoR]

Changes in Hair Density of the Free Flap Following Preoperative Laser Depilation of Donor Site in Head and Neck Cancer Free Flap Reconstruction [LaDDoR]


Sponsor

Chris O'Brien Lifehouse

Enrollment

70 participants

Start Date

Apr 1, 2025

Study Type

Interventional

Conditions

Summary

The purpose of this research is to determine the effectiveness of laser treatment on the leg or arm that will be used to reconstruct your mouth after a removal of cancer before the surgery in reducing hair density in the mouth, and to assess overall satisfaction, including comfort and oral hygiene post-surgery. Who is it for? You may be eligible to join this study if you are aged 18 years and older, have head and neck cancer and will undergo free flap reconstruction using hair-bearing donor site. Study Details: By participating in this study, you will be randomised to either the control group (no laser hair removal treatment) or the intervention group (laser hair removal treatment). Following your surgery, an assessment will be conducted while you are still in hospital to review your healing of donor site/free flap as a standard of care. Hair density measurements and a review of the free flap will also be conducted at your routine post operative review at 4 weeks and 12 weeks post-op. Functional and health-related quality of life [HRQOL] patient reported outcome data will be collected using the FACE-Q Head and Neck Module questionnaire at the first appointment and 12 weeks postop. It is hoped that findings from this study will help clinicians and researchers understand the utility of pre-operative laser treatment in improving quality of life for those undergoing head and neck reconstruction.


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

When surgeons remove cancer from the head or neck, they sometimes need to use a piece of skin and tissue from elsewhere on the body — typically the forearm or lower leg — to reconstruct the area. This is called a 'free flap' reconstruction. One challenge is that if the donor skin bears hair, that hair can continue to grow inside the mouth or throat after surgery, which can be uncomfortable, unhygienic, and distressing for patients. The LaDDoR study is testing whether performing laser hair removal on the donor site before surgery can reduce hair growth inside the mouth following reconstruction. Participants will be randomly assigned to receive laser hair removal treatment on the donor site prior to their surgery, or to receive no pre-treatment. Researchers will then track hair density, wound healing, and patient-reported satisfaction and oral quality of life at 4 and 12 weeks after surgery. You may be eligible if you are aged 18 or older, have been diagnosed with head and neck cancer, and are scheduled to undergo free flap reconstruction using a hair-bearing donor site (such as from the forearm or lower leg). People who will be receiving post-operative radiotherapy, or those with conditions such as photosensitivity, keloids, or use of light-sensitising medications would not be eligible.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Primary objective is to compare changes in the hair density of the free flap at key points of reconstruction: preoperatively and postoperatively for intervention and control groups. Interventions i

Primary objective is to compare changes in the hair density of the free flap at key points of reconstruction: preoperatively and postoperatively for intervention and control groups. Interventions include: Appointment 1: Approx. 3weeks preop Eligibility screen and Informed consent Hair density measurement. Hair density in your donor site will be measured by clipping the hair, placing a custom 3D printed “ruler” and taking the photographs which will take approximately 15 to 30 minutes. Functional and health-related quality of life [HRQOL] Questionnaire. which will take approximately 10 – 15 minutes Appointment 2 and 3: Laser treatment session (intervention group). Participants in the intervention group will undergo laser depilatory treatment to their donor site at Contour clinics, a laser clinic external to Chris O’Brien Lifehouse (no out-of-pocket cost for participant for laser treatment). A depilation guide marking the specific areas for laser treatment will be created and distributed to the laser technician. The first laser session will be completed within a week of signing the consent form (approximately 2.5 weeks before your surgery), and the second session will be completed at least 3 days prior to your surgery. The sessions will be roughly 2 weeks apart and this will allow adequate time for common acute effects, such as erythema and pain, to resolve. Each laser session will take approximately 60 minutes. A treatment questionnaire including adverse event assessment and a visual analogue pain scale assessing the tolerability of treatment will be completed by participants on the same day of the intervention (via online or paper form already provided to participants). This will take approximately 5 -10 minutes. Follow up: An inpatient assessment will be conducted day 5 (+/- 2 days) post-op to review flap in the recipient site and record post-operative complications. Hair density measurements at the recipient site and review of the donor site at 4- and 12-week routine postoperative clinic. The HRQOL questionnaire will be repeated at 12-week routine postoperative clinic or will be emailed/mailed to a participant. Other than the laser depilation to the donor site prior to surgery, patients will be treated as per the usual standard of care for head and neck cancer reconstruction.


Locations(1)

Chris O’Brien Lifehouse - Camperdown

NSW, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12625000040460


Related Trials